Holen Sie sich die Stockscreener-App
1.56
0.64%
-0.01
Handel nachbörslich:
1.54
-0.02
-1.28%
Schlusskurs vom Vortag:
$1.57
Offen:
$1.61
24-Stunden-Volumen:
368.07K
Relative Volume:
0.61
Marktkapitalisierung:
$61.79M
Einnahmen:
$41.21M
Nettoeinkommen (Verlust:
$-15.12M
KGV:
-4.3345
EPS:
-0.3599
Netto-Cashflow:
$-17.19M
1W Leistung:
-4.88%
1M Leistung:
+4.70%
6M Leistung:
+130.91%
1J Leistung:
+74.89%
1-Tages-Spanne:
$1.49
$1.63
1-Wochen-Bereich:
$1.49
$1.70
52-Wochen-Spanne:
$0.605
$1.885
Myomo Inc Stock (MYO) Company Profile
Firmenname
Myomo Inc
Sektor
Branche
Telefon
617-996-9058
Adresse
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.56 | 63.77M | 41.21M | -15.12M | -17.19M | -0.3599 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-20 | Eingeleitet | Lake Street | Buy |
| 2023-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Dougherty & Company | Buy |
| 2017-10-02 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Myomo Inc Aktie (MYO) Neueste Nachrichten
Myomo raises FY26 sales guidance to $45-47 million range - scanx.trade
Myomo Q2FY26 Results: Revenue up 21%, guidance raised to $45-47 million - scanx.trade
Myomo Q2 2026 Earnings Call Transcript - Benzinga
Myomo Inc. (MYO) Q2 2026 Earnings: Wider-Than-Expected Loss Met With Modest Stock GainQuarterly Earnings Report - dars.gov.et
ETFs Investing in Myomo, Inc. Stocks - TradingView
Myomo Inc (MYO) Chief Medical Officer Harry Kovelman Sells 15,48 - GuruFocus
Myomo (NYSE: MYO) insider to sell 15,844 shares after two recent sales - Stock Titan
Director of Myomo (NYSE: MYO) moves to sell shares from recent stock awards - Stock Titan
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeFactor Valuation - vinanet.vn
MYO Q2 2026 Earnings: EPS Miss of 18.81% Sends Shares Down 4.9%Earnings Decline Risk - vinanet.vn
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $10.5 - Moomoo
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $30,329 in stock - Investing.com
Myomo (MYO) Latest: Moves 0.57% Lower to $1.73 on the Day; Technical View - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionGross Profit Margin - vinanet.vn
Myomo chief medical officer sells $29,895 in shares - Investing.com India
Insider Selling: Myomo (NYSEAMERICAN:MYO) Insider Sells 17,250 Shares of Stock - MarketBeat
Myomo chief medical officer sells $29,895 in shares By Investing.com - Investing.com South Africa
Myomo (NYSE: MYO) officer eyes 17,500-share stock sale - Stock Titan
Rosalind Advisors, Inc. Expands Myomo Inc (MYO) Stake -- Shares Trade 48% Below GF Value - GuruFocus
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - qz.com
Myomo Inc. (MYO) Q2 2026 Earnings: EPS Misses Estimates as Loss Deepens, Shares Edge Up - Vinanet
Myomo (MYO): Rosalind Master Fund reports 9.18% stake and warrant blocker - Stock Titan
Q1 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 Earnings Estimate for Myomo Issued By HC Wainwright - MarketBeat
MYO Q2 2026 Earnings: EPS Miss of 18.8% Weighs on Shares as Loss DeepensProfit Recovery Report - dars.gov.et
Myomo Q2 Earnings Call Highlights - sharewise.com
A Quick Look at Today's Ratings for Myomo(MYO.US), With a Forecast Between $1.7 to $5 - Moomoo
Myomo revenue up 21% to USD 11.7M in Q2 2026 - Medical Buyer
Myomo earnings beat by $0.01, revenue topped estimates - Investing.com Nigeria
Craig-Hallum Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $1.7 - Moomoo
Myomo Inc. (MYO) Surges 19% as Medical Robotics Stock Tests Key ResistanceOvervalued Signals - dars.gov.et
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive Strong Quarter - GuruFocus
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive ... - Yahoo Finance
Myomo Reports Second Quarter 2026 Financial and Operating Results - BioSpace
Earnings call transcript: Myomo tops Q2 2026 estimates and lifts revenue view - Investing.com
Is Myomo Inc (MYO) a Hidden Gem? Q2 Earnings Show Revenue of $11 - GuruFocus
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Aug 05 (Reuters)Myomo Inc Q2 Operating Exp - Moomoo
MYOMO INC Q2 NET INCOME USD -1.2 MILLION - Moomoo
Q2 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Press Release: Myomo Reports Second Quarter 2026 Financial and Operating Results - moomoo.com
Myomo(MYO) Stock Options Chain | Quotes & News - Moomoo
Myomo Q3 Results: Sales guidance beats analyst estimates - scanx.trade
MYO Q1 2026 Earnings: Loss Narrows to $0.05 Per Share, Beating Estimates by 56.6%Tangible Book Value - vinanet.vn
Myomo Adds Seventh Director to its Board - mpo-mag.com
Earnings Preview: Myomo to Report Financial Results Post-market on August 05 - Moomoo
Myomo Inc. (MYO) Pushes Toward Resistance After 7.5% Gain — Key Levels to WatchJelly Roll Trade - careplusvn.com
Myomo Inc. Q1 2026 Earnings: Wider-Than-Expected Loss but Significant EPS Surprise Marks ProgressQuarterly Profit Report - dars.gov.et
Finanzdaten der Myomo Inc-Aktie (MYO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):